Location History:
- Kobe, JA (1976)
- Kobe, JP (1979 - 1992)
Company Filing History:
Years Active: 1976-1992
Title: Mikio Kurokawa: Innovator in Pharmaceutical Science
Introduction
Mikio Kurokawa is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical science, particularly in the treatment of ischemic brain damage. With a total of 6 patents to his name, Kurokawa's work has had a meaningful impact on medical research and development.
Latest Patents
One of Kurokawa's latest patents is an agent for treating ischemic brain damage, which involves dibenz[b,e]oxepin derivatives and a pharmaceutical composition containing these compounds. This innovative approach aims to provide new therapeutic options for patients suffering from brain injuries.
Career Highlights
Kurokawa is currently associated with Dainippon Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work at this esteemed company has allowed him to explore new avenues in drug formulation and therapeutic applications.
Collaborations
Throughout his career, Kurokawa has collaborated with notable colleagues, including Hitoshi Uno and Yoshinobu Masuda. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Mikio Kurokawa's contributions to pharmaceutical science exemplify the spirit of innovation in the medical field. His dedication to developing effective treatments for ischemic brain damage showcases the importance of research and collaboration in advancing healthcare solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.